Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin T vs I
Luca KoechlinJasper BoeddinghausDimitrios DoudesisPedro Lopez-AyalaTobias ZimmermannKlara RumoraJeanne du Fay de LavallazZiwen LiKuan Ken LeeAndrew R ChapmanKarin WildiDanielle Menosi GualandroMuntadher Al KaramMaría Rubini GiménezGabrielle HuréÓscar MiróZoe KleinPaolo BimaDesirée WusslerMichael ChristIvo StrebelFrancisco Javier Martín‐SánchezDamian KaweckiDagmar I. KellerOliver ReuthebuchKatharina RentschAnna MarsanoAndreas BuserThomas NestelbergerChristian PuelacherFelix MahfoudNicholas L. MillsChristian Mueller
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceKey expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“It is reassuring for clinicians to know that both hs-cTnT and hs-cTnI perform exceptionally well for the early diagnosis of myocardial infarction when applied within a triage algorithm, such as the European Society of Cardiology 0/1-hour algorithm. Both assays provide high safety for ruling out myocardial infarction and excellent accuracy for ruling it in.”
“This article doesn't show anything convincingly new between high-sensitivity troponin I and high-sensitivity troponin T.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Koechlin et al. (2024) studied this question.